Literature DB >> 27911032

A Dermal Equivalent Engineered with TGF-β3 Expressing Bone Marrow Stromal Cells and Amniotic Membrane: Cosmetic Healing of Full-Thickness Skin Wounds in Rats.

Ali Samadikuchaksaraei1,2,3, Ahmad Mehdipour2, Mehryar Habibi Roudkenar4, Javad Verdi5, Mohammad Taghi Joghataei1, Kamran As'adi6, Fatemeh Amiri4, Mozhgan Dehghan Harati7, Mazaher Gholipourmalekabadi1,2,8, Nushin Karkuki Osguei9.   

Abstract

Transforming growth factor beta-3 (TGF-β3) has been shown to decrease scar formation after scheduled topical applications to the cutaneous wounds. This study aimed to continuously deliver TGF-β3, during the early phase of wound healing, by engineering a dermal equivalent (DE) using TGF-β3 expressing bone marrow stromal cells (BM-SCs) and human dehydrated amniotic membrane (hDAM). To engineer a DE, rat BM-SCs were seeded on the hDAM and TGF-β3 was transiently transfected into the BM-SCs using a plasmid vector. Pieces of the dermal equivalent were transplanted onto the full-thickness excisional skin wounds in rats. The process of wound healing was assessed by image analysis, Manchester Scar Scale (MSS), and histopathological studies 7, 14, 21, and 85 days after the excision. The results confirmed accurate construction of recombinant pcDNA3.1-TGF-β3 expression system and showed that the transfected BM-SCs seeded on hDAM expressed TGF-β3 mRNA and protein from day 3 through day 7 after transfection. After implantation of the DE, contraction of the wounds was measured from day 7 through 21 and analyzed by linear regression, which revealed that the rate of wound contraction in all experimental groups was similar. Histologic evaluation demonstrated that transfected BM-SCs decreased retention and recruitment of the cells during the early stage of wound healing, decreased the formation of vascular structures and led to formation of uniformly parallel collagen bundles. MSS scores showed that TGF-β3 secreting cells significantly improved the cosmetic appearance of the healed skin and decreased the scar formation. From these results, it could be concluded that transient secretion of TGF-β3, during the early phase of healing, by BM-SCs seeded on hDAM can improve the cosmetic appearance of the scar in cutaneous wounds without negatively affecting the process of wound repair.
Copyright © 2016 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Cicatrix; Keloid; Re-epithelialization; Scar; Transforming growth factor beta-3

Mesh:

Substances:

Year:  2016        PMID: 27911032     DOI: 10.1111/aor.12807

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

Review 1.  Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.

Authors:  Jacqueline Larouche; Sumit Sheoran; Kenta Maruyama; Mikaël M Martino
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

Review 2.  Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge.

Authors:  Hoda Elkhenany; Azza El-Derby; Mohamed Abd Elkodous; Radwa A Salah; Ahmed Lotfy; Nagwa El-Badri
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

Review 3.  Designer Exosomes: A New Platform for Biotechnology Therapeutics.

Authors:  Davod Jafari; Samira Shajari; Rasool Jafari; Narges Mardi; Hosna Gomari; Fatemeh Ganji; Mehdi Forouzandeh Moghadam; Ali Samadikuchaksaraei
Journal:  BioDrugs       Date:  2020-10       Impact factor: 5.807

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.